Narcolepsy following <scp>COVID</scp>‐19: A case report and review of potential mechanisms
Yazdani Roya, Farzaneh Barzkar, Almasi‐Dooghaee Mostafa, Shojaie Mahsa, Babak Zamani
Abstract
Key Clinical Message: The immune activation in COVID-19 may trigger narcolepsy in vulnerable patients. We suggest clinicians carefully evaluate patients with post-COVID fatigue and hypersomnia for primary sleep disorders, specifically narcolepsy. Abstract: The patient is a 33-year-old Iranian woman without a significant past medical history with the full range of narcolepsy symptoms that started within 2 weeks after her recovery from COVID-19. Sleep studies revealed increased sleep latency and three sleep-onset rapid eye movement events, compatible with a narcolepsy-cataplexy diagnosis.
Topics & Concepts
NarcolepsyMedicineCataplexyCoronavirus disease 2019 (COVID-19)Multiple Sleep Latency TestSleep (system call)2019-20 coronavirus outbreakSleep disorderSleep paralysisSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PediatricsModafinilPsychiatryInsomniaExcessive daytime sleepinessInternal medicineInfectious disease (medical specialty)PathologyDiseaseOutbreakComputer scienceOperating systemSleep and Wakefulness ResearchSleep and related disordersLong-Term Effects of COVID-19